Nu siwo ate ŋu ana suklidɔ nadze ame dzi dometɔ aɖewoe nye:
1. Suklidɔlélawo ƒe ŋutinya le ƒomea me: Ne suklidɔ le dzila alo nɔvi aɖe ŋu la, ate ŋu ana wò hã nàdze dɔ.
2. Ƒexɔxɔ: Ne èle tsitsim la, ele bɔbɔe be suklidɔ ƒomevi evelia nadze dziwò, vevietɔ ne èxɔ tso ƒe 45 heyina.
3. Kpekpeme: Ne èlolo akpa alo nèlolo akpa la, ate ŋu ana nàdze dɔ.
4. Kamedede fũu akpa: Kamedede fũu akpa ate ŋu ana nàdze dɔ bɔbɔe.
5. Ameƒomevi alo to si me tɔ nènye: Amesiwo tso to aɖewo me, abe Afrikatɔwo, Amerikatɔ siwo nye Spaintɔwo, Amerikatɔ Gbãtɔwo, kple Asiatɔ siwo nye Amerikatɔwo ene, ate ŋu alé suklidɔ ƒomevi evelia bɔbɔe wu.
6. Suklidɔ si dzea funɔwo dzi: Ele bɔbɔe be suklidɔ ƒomevi evelia nava dze nyɔnu siwo ŋu suklidɔ le le fufɔɣi la dzi emegbe.
7. Azigolo ƒe akpa si me dɔlékuiwo sɔa gbɔ ɖo: Ele bɔbɔe be suklidɔ ƒomevi evelia nadze nyɔnu siwo ŋu dɔléle sia le la dzi.
8. Dɔléle si nana ame ƒe lãmetsiwo trɔna kabakaba: Dɔléle siawo siwo dometɔ aɖewoe nye ʋusɔgbɔdɔ, ʋumemi ƒe agbɔsɔsɔme si sɔ gbɔ, kple alime ƒe lolome si lolo la, nana be suklidɔ ƒomevi evelia tea ŋu dzea ame dzi bɔbɔe.
9. Atamanono: Atamanono ate ŋu ana insulin magate ŋu awɔ dɔ le lãme na ame o, si ate ŋu ana suklidɔ ƒomevi evelia nadze ame dzi.
10. Suklidɔ si nu mesẽna o: Ne suklidɔ si nu mesẽna o le ame aɖe ŋu la, ate ŋu adze suklidɔ ƒomevi evelia.
11. Vidzĩwo ƒe kpekpeme dzi ɖe kpɔtɔ: Ne vidzĩwo ƒe kpekpeme dzi ɖe kpɔtɔ la, ate ŋu adzɔ be suklidɔ ƒomevi evelia nava nɔ fu ɖem na wo emegbe.
12. Ʋusɔgbɔdɔ: Ne ʋusɔgbɔdɔ le ame ŋu la, ate ŋu ana be suklidɔ ƒomevi evelia nava ɖe fu nɛ.
13. Ʋumenu siwo nana ame ƒe lãme wɔa dɔ nyuie kple ʋumenu siwo nana ame ƒe lãme wɔa dɔ nyuie o: Ne ʋumenu siwo nana lãme wɔa dɔ nyuie ƒe agbɔsɔsɔ sɔ gbɔ eye ʋumenu siwo nana lãme wɔa dɔ nyuie ƒe agbɔsɔsɔ hã le sue la, ate ŋu ana ame nava lé suklidɔ ƒomevi evelia.
14. Alɔ̃madɔmadɔ: Amesiwo ŋu alɔ̃madɔmadɔ le la ate ŋu alé suklidɔ ƒomevi evelia.
15. Nuteɖeamedzi: Nuteɖeamedzi atraɖii ate ŋu ana be suklidɔ ƒomevi evelia nava ɖe fu na ame bɔbɔe.
17. Dzidede: Dzidede atraɖii ate ŋu ana be suklidɔ ƒomevi evelia nava lé ame geɖe.
18. Anyinɔnɔ ʋuu: Anyinɔnɔ ʋuu ate ŋu ana suklidɔ ƒomevi evelia nadze ame dzi bɔbɔe.
19. Nuɖuɖu si me ami kple ŋusẽ geɖe le: Nuɖuɖu si me ami kple ŋusẽ geɖe le ate ŋu ana suklidɔ ƒomevi evelia nadze ame dzi.
20. Aha Muamewo nono: Aha muamewo nono fũu akpa ate ŋu ana be suklidɔ ƒomevi evelia nava ɖe fu na ame bɔbɔe.
21. Alɔ̃madɔmadɔ: Alɔ̃madɔmadɔ ate ŋu ana be suklidɔ ƒomevi evelia nava lé ame bɔbɔe.
22. Ya ƒe ɖiƒoƒo: Ya ƒe ɖiƒoƒo ate ŋu ana suklidɔ ƒomevi evelia nadze ame dzi bɔbɔe.
Dɔlékui aɖewo: Dɔlékui aɖewo abe aklãdɔ si naa ame ƒe aklã lia zi geɖe ene ate ŋu ana be suklidɔ ƒomevi evelia nava lé ame bɔbɔe.
24. Homocysteine ƒe agbɔsɔsɔme si sɔ gbɔ: Amino acid si nye homocysteine ƒe agbɔsɔsɔme si sɔ gbɔ ate ŋu ana suklidɔ ƒomevi evelia nadze ame dzi.
25. Uric acid ƒe agbɔsɔsɔme si sɔ gbɔ: Uric acid si nye nusiwo gblẽna le ŋutilã ŋu ƒe agbɔsɔsɔme si sɔ gbɔ ate ŋu ana suklidɔ ƒomevi evelia nadze ame dzi.
26. C-reactive protein ƒe agbɔsɔsɔme si sɔ gbɔ: C-reactive protein si sɔ gbɔ, si nye nusiwo fiaa alesi dɔlélea le nu gblẽm le ame ŋu la, ate ŋu ana be suklidɔ ƒomevi evelia nava lé ame geɖe.
27. Fibrinogen ƒe agbɔsɔsɔme si sɔ gbɔ: Fibrinogen, si nye protein si nana ʋu blana la ƒe agbɔsɔsɔme si sɔ gbɔ ate ŋu ana be suklidɔ ƒomevi evelia nava lé ame.
PAI-1 ƒe agbɔsɔsɔme si sɔ gbɔ: PAI-1, si nye protein si nana ʋu blana la ƒe agbɔsɔsɔme si sɔ gbɔ ate ŋu ana be suklidɔ ƒomevi evelia nava lé ame.
Leptin ƒe agbɔsɔsɔme si sɔ gbɔ: Leptin, si nye lãmetsi aɖe si kpɔa ŋusẽ ɖe nuɖuɖu dzroame dzi la ƒe agbɔsɔsɔme si sɔ gbɔ ate ŋu ana suklidɔ ƒomevi evelia nadze ame dzi.
30. Resistin ƒe agbɔsɔsɔme si sɔ gbɔ: Resistin, si nye lãmetsi si naa insulin megate ŋu wɔa dɔ o ƒe agbɔsɔsɔme si sɔ gbɔ ate ŋu ana be dɔléle si nye
King WM, Saseen JJ, Anderson SL: Characterization of diabetes risk factors in patients prescribed chronic statin therapy. Ther Adv Chronic Dis. 2014, 5 (5): 206-11.
Bielinski SJ, Pankow JS, Rasmussen-Torvik LJ, Bailey K, Li M, Selvin E, Couper D, Vazquez G, Brancati F: Strength of association for incident diabetes risk factors according to diabetes case definitions: the Atherosclerosis Risk in Communities Study. Am J Epidemiol. 2012, 175 (5): 466-72.
Gangwisch JE, Gross R, Malaspina D: Differential Associations Between Depression, Risk Factors for Insulin Resistance and Diabetes Incidence in a Large U.S. Sample. Isr J Psychiatry Relat Sci. 2015, 52 (2): 85-90.
Leiva AM, Martínez MA, Petermann F, Garrido-Méndez A, Poblete-Valderrama F, Díaz-Martínez X, Celis-Morales C: [Risk factors associated with type 2 diabetes in Chile]. Nutr Hosp. 2018, 35 (2): 400-407.
Chatterjee R, Maruthur NM, Edelman D: Novel Risk Factors for Type 2 Diabetes in African-Americans. Curr Diab Rep. 2015, 15 (12): 103.
Higa S, Maesato A, Ishigaki S, Suenari K, Chen YJ, Chen SA: Diabetes and Endocrine Disorders (Hyperthyroidism/Hypothyroidism) as Risk Factors for Atrial Fibrillation. Card Electrophysiol Clin. 2021, 13 (1): 63-75.
Brodalko B: [Diabetes risk factors in the Regional Railway Hospital in Lublin, described on the basis of medical documentation]. Wiad Lek. 2000, 53 (5-6): 255-61.
['Mɔxeɖenu: atikewɔwɔ']
['Taɖodzinu siwo nye nufiafia kple nyatakaka koe le nyatakakadzraɖoƒe sia ŋu eye menye atikewɔwɔ ŋuti ɖaŋuɖoɖo alo dɔwɔnawo ƒe nya gblɔm wole o.']
['Mele be woazã nyatakaka siwo wona la atsɔ ada dɔléle alo dɔ aɖe o, eye ele be amesiwo di be yewoakpɔ atikewɔwɔ ŋuti ɖaŋuɖoɖo na yewo la nabia ɖɔkta si xɔ mɔɖegbalẽ.']
['De dzesii be neural network si wɔa nyabiabiawo ƒe ŋuɖoɖowo la meɖia o vevietɔ ne wotsɔ xexlẽdzesiwo wɔe. Le kpɔɖeŋu me, ne wotsɔ ame siwo ŋu dɔléle aɖe le ƒe xexlẽme wɔ dɔe.']
['Bia wò ɖɔkta alo lãmesẽdɔwɔla bubu si dze ƒe aɖaŋuɖoɖo ɣesiaɣi le lãmesẽkuxi aɖe ŋu. Mègaŋe aɖaba ƒu aɖaŋuɖoɖo si ɖɔktawo ɖo na wò alo gbɔ dzi ɖi le exexlẽ me le nyatakakadzraɖoƒe sia ta o. Ne èsusu be ɖewohĩ lãmesẽkuxi aɖe le fu ɖem na ye la, ke yɔ 911 alo yi ɖe afisi wokpɔa nɔnɔme kpatawo gbɔ le.']
['Copyright: Copyright']
['Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the DMCA) na mɔ siwo dzi copyright ƒe nunɔlawo ate ŋu ato awɔ nu ɖe nu siwo wo xɔ se be wo le Internet dzi la ŋu.']
['Ne èxɔe se kple kakaɖedzi be nyatakakadzraɖoƒe alo dɔwɔnu aɖe si míetsɔ wɔ míaƒe nyatakakadzraɖoƒea alo dɔwɔnawo la nye dada le wò gome la, wò ŋutɔ (alo wò dɔtɔ) ate ŋu aŋlɔ agbalẽ aɖo ɖe mí abia be míaɖe nyatakakadzraɖoƒea alo dɔwɔnua ɖa alo axe mɔ ɖe ezazã nu.']
['Ele be woana nyatakakawo to e-mail dzi (kpɔ "Kpekpeɖeŋunaƒe" ƒe akpa si nye e-mail adrɛs). ']
['DMCA bia be nàŋlɔ nyatakaka siwo gbɔna ɖe wò nyatakaka si nèŋlɔ be woada le copyright dzi la me: (1) nuŋɔŋlɔ si fia be copyright le dɔ si ŋu wole nu ƒom le la ŋu; (2) nyatakaka si fia be nuŋɔŋlɔa le eme eye wòade mía nu be míake ɖe eŋu; (3) nyatakaka siwo ana míake ɖe ŋuwò, siwo dometɔ aɖewoe nye wò adrɛs, kaƒodzesi kple e-mail adrɛs; (4) wò nya si fia be èxɔe se kple kakaɖedzi be copyright ƒe ame si tɔe nyatakakaa nye, alo eƒe dɔtɔ, alo se aɖeke meɖe mɔ ɖe eŋu o; ']
['(5) Wò ŋutɔ nàŋlɔ agbalẽ si dzi nàde asii, si me nàde se be ne mèwɔe o la, àda alakpa, atsɔ aɖo kpe edzi be nyatakaka siwo le nyatakakaa me la de pɛpɛpɛ eye be ŋusẽ le asiwò be nàʋli agbalẽ siwo ŋu wogblɔ le be woda le la ta.']
['Eye (6) ame si tɔe agbalẽa nye alo ame si wona ŋusẽe be wòawɔ dɔ le ame si tɔ ŋkɔ me la ƒe asinuŋɔŋlɔ alo eƒe asinuŋɔŋlɔ si le mɔ̃ dzi. ']
['Ne mèŋlɔ nyatakaka siwo katã le etame ɖe agbalẽa me o la, ate ŋu ana be wò nyatoƒoe me dzodzro natsi megbe.']
['Kadodo']
['Taflatse ɖo email ɖe mí ne nyabiabia alo aɖaŋuɖoɖo aɖe le asiwò.']
What are the risk factors for diabetes?
There are several risk factors for diabetes, including:
1. Family history: Having a parent or sibling with diabetes increases your risk.
2. Age: The risk of type 2 diabetes increases as you get older, especially after age 45.
3. Weight: Being overweight or obese increases your risk.
4. Physical inactivity: Lack of exercise can increase your risk.
5. Race or ethnicity: Certain ethnic groups, such as African Americans, Hispanic Americans, Native Americans, and Asian Americans, have a higher risk of developing type 2 diabetes.
6. Gestational diabetes: Women who have had gestational diabetes during pregnancy are at higher risk of developing type 2 diabetes later in life.
7. Polycystic ovary syndrome: Women with this condition have a higher risk of developing type 2 diabetes.
8. Metabolic syndrome: This cluster of conditions, including high blood pressure, high cholesterol, and large waist circumference, increases the risk of type 2 diabetes.
9. Smoking: Smoking can increase insulin resistance, which can lead to type 2 diabetes.
10. Prediabetes: Having prediabetes, or higher than normal blood sugar levels, increases the risk of developing type 2 diabetes.
11. Low birth weight: Babies with low birth weight have a higher risk of developing type 2 diabetes later in life.
12. High blood pressure: Having high blood pressure increases the risk of developing type 2 diabetes.
13. Abnormal cholesterol and triglyceride levels: High levels of triglycerides and low levels of HDL (good) cholesterol increase the risk of type 2 diabetes.
14. Sleep apnea: People with sleep apnea have an increased risk of developing type 2 diabetes.
15. Stress: Chronic stress can increase the risk of developing type 2 diabetes.
16. Certain medications: Some medications, such as steroids and antipsychotics, can increase the risk of developing type 2 diabetes.
17. Inflammation: Chronic inflammation can increase the risk of developing type 2 diabetes.
18. Sedentary lifestyle: A sedentary lifestyle can increase the risk of developing type 2 diabetes.
19. High-fat, high-calorie diet: Consuming a diet high in unhealthy fats and calories can increase the risk of developing type 2 diabetes.
20. Alcohol consumption: Excessive alcohol consumption can increase the risk of developing type 2 diabetes.
21. Sleep deprivation: Inadequate sleep can increase the risk of developing type 2 diabetes.
22. Air pollution: Exposure to air pollution can increase the risk of developing type 2 diabetes.
23. Certain infections: Certain infections, such as hepatitis C, can increase the risk of developing type 2 diabetes.
24. High levels of homocysteine: High levels of homocysteine, an amino acid, can increase the risk of developing type 2 diabetes.
25. High levels of uric acid: High levels of uric acid, a waste product, can increase the risk of developing type 2 diabetes.
26. High levels of C-reactive protein: High levels of C-reactive protein, a marker of inflammation, can increase the risk of developing type 2 diabetes.
27. High levels of fibrinogen: High levels of fibrinogen, a protein involved in blood clotting, can increase the risk of developing type 2 diabetes.
28. High levels of PAI-1: High levels of PAI-1, a protein involved in blood clotting, can increase the risk of developing type 2 diabetes.
29. High levels of leptin: High levels of leptin, a hormone involved in appetite regulation, can increase the risk of developing type 2 diabetes.
30. High levels of resistin: High levels of resistin, a hormone involved in insulin resistance, can increase the risk of developing
Disclaimer: medical
This web site is provided for educational and informational purposes only and does not constitute providing medical advice or professional services.
The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician.
Please note the neural net that generates answers to the questions, is specially inaccurate when it comes to numeric content. For example, the number of people diagnosed with a specific disease.
Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. Neither BioMedLib nor its employees, nor any contributor to this web site, makes any representations, express or implied, with respect to the information provided herein or to its use.
Disclaimer: copyright
The Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the “DMCA”) provides recourse for copyright owners who believe that material appearing on the Internet infringes their rights under U.S. copyright law. If you believe in good faith that any content or material made available in connection with our website or services infringes your copyright, you (or your agent) may send us a notice requesting that the content or material be removed, or access to it blocked. Notices must be sent in writing by email (see 'Contact' section for email address) . The DMCA requires that your notice of alleged copyright infringement include the following information: (1) description of the copyrighted work that is the subject of claimed infringement; (2) description of the alleged infringing content and information sufficient to permit us to locate the content; (3) contact information for you, including your address, telephone number and email address; (4) a statement by you that you have a good faith belief that the content in the manner complained of is not authorized by the copyright owner, or its agent, or by the operation of any law; (5) a statement by you, signed under penalty of perjury, that the information in the notification is accurate and that you have the authority to enforce the copyrights that are claimed to be infringed; and (6) a physical or electronic signature of the copyright owner or a person authorized to act on the copyright owner’s behalf. Failure to include all of the above information may result in the delay of the processing of your complaint.
['Le Eŋu']
['BioMedLib zãa kɔmpiuta siwo wɔa dɔ le wo ɖokui si (mɔ̃ siwo zãa mɔ̃ɖaŋunuwo tsɔ srɔ̃a nu) tsɔ wɔa nyabiabia kple ŋuɖoɖowo.']
